 
Name:  ___           Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine-Iodine Containing / Iodinated Contrast Media - IV Dye
 
Attending: ___
 
Chief Complaint:
Weight Loss, Right Mouth Pain.
 
Major Surgical or Invasive Procedure:
ENT Endoscopic Examination ___
PEG Tube Placement ___

 
History of Present Illness:
Mr. ___ is a ___ year old male, with past history of HPV+ 
Oropharyngeal T2, N2a, Stage ___ squamous cell carcinoma of the 
tonsil, treated with cisplatin and IMRT (30 fractions with 
delivery to gross and nodal disease), now presenting with 
increased weight loss, and worsening right tooth pain. 

Patient reports that his current symptoms are very similar to 
his prior symptoms of when he was diagnosed. During his 
chemotherapy, and half way through his radiation therapy, he had 
interval improvement in his right jaw pain to the point where it 
had gone away. Patient had a 30 lb reported weight loss during 
the time of his therapy, and then reports that over the past 3 
weeks he has been having increased difficulty with eating and 
therefore reports about a 20 lb weight loss. He states this is 
very reminiscent of his prior diagnosis where he had pain that 
then resolved. He also reports that he has been unable to really 
open his mouth, and has had 4 episodes of nausea/vomiting, with 
cottage cheese emesis. It has become much harder for him to eat, 
and he has been eating more liquids. Patient reports that he has 
been having about ___ pain, worse with swallowing, and touching 
the right side of his jaw, and this radiates across the anterior 
aspect of his ___, temporal area to the back of his head. 

Notably, patient was last seen on ___ by radiation oncology 
for an earache. At that time, it was noted that he had completed 
3 month interval from chemotherapy and radiation, and an ongoing 
earache for which he was given oxycodone without any significant 
effect. He was also complaining of odynophagia, and was trying 
to drink supplements ___ cans / day. Patient was also found to 
have thrush, for which he was given a 2 week script for 
fluconazole. 

In the ED, initial vitals: 9 98.6 129 114/87 18 100% RA 
- Exam notable for right sided facial swelling.  
- Labs were notable for: WBC 8.1, Hgb 14, hct 40.5, Platelet 
280. Lactate 2.0. Sodium 133, Chloride 90, BUN 25, Creatinine 
0.8. Bicarb 17. Calcium9.7, Magnesium 2, Phosph 3. ALT 14, AST 
32, T-bili 0.6, Albumin 4. TSH 0.51.
- Imaging: None obtained. 
- Patient was given:  
___ 11:19 IV Ondansetron 4 mg 
___ 11:19 IVF  NS ( 1000 mL ordered)
___ 13:03 IV Ondansetron 4 mg   
___ 13:19 IV Morphine Sulfate 4 mg 

- Decision was made to admit to ___ for increased pain, 
dehydration, and PO intolerance. 

- Vitals prior to transfer were 98.9 100 119/79 100% RA 

On arrival to the floor, patient reports that he is having right 
jaw pain. 

REVIEW OF SYSTEMS: 
A complete 10-point review of systems was performed and was 
negative unless otherwise noted in the HPI.
 
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
- ___ he was started on Cisplatin and RT.
- ___ - ___ - Admission for nausea, vomiting and
bleeding from oral cavity
- ___ C2 Cisplatin
- ___ - ___ - Admission for throat pain, inability to
take PO and vomiting
- Cisplatin discontinued - patient decided not to receive the
third cycle.
- ___ - Completion of RT.

PAST MEDICAL HISTORY:
1. Graves disease
2. Kidney stones
3. Sleep apnea
4. Anxiety with OCD features
5. Oropharyngeal cancer  

Past Surgical History:
1. Carpal tunnel syndrome

 
Social History:
___
Family History:
Mother has ___ disease, father has emphysema, uncle 
diagnosed with head and neck cancer.
 
Physical Exam:
ADMISSION EXAM
==============
GENERAL: Patient is fatigued appearing. He is quite dry in the 
mouth, no cyanosis, no tachypnea, able to converse, voice is 
good. 
HEENT: There is significant right sided swelling, submandibular, 
and right throat. He pain radiates across temporal area, but no 
tenderness to significant palpation distinctly in the right 
temporal area. 
NECK: As above. Left side is quite small, no major cervical 
lymphadenopathy appreciated. 
LUNGS: low lung volumes, no rhonchi heard. 
CV: Tachycardic, S1, S2. No extra sounds. 
ABD: Flat, abdomen, + BS. 
EXT: No ___ edema bilaterally, sensation intact. 
SKIN: Dry. 
NEURO: CN II-XII grossly intact. 
ACCESS: Peripheral.
 
DISCHARGE EXAM
==============
Physical Exam:  
Vitals: T max 98.2-98.6  BP ___  ___  18  97RA
GENERAL: NAD, no cyanosis, no tachypnea, able to converse, voice 
is at baseline according to patient and sounds normal. Very 
thin.
HEENT: Dry mucous membranes. There is significant right sided 
swelling, submandibular, and right throat. no tenderness to 
significant palpation distinctly in the right temporal area. 
NECK: As above. Left side is quite small, no major cervical 
lymphadenopathy appreciated. 
LUNGS: low lung volumes, no rhonchi heard. no wheezing. 
CV: RRR, S1, S2. No extra sounds. 
ABD: Flat, abdomen, + BS. 
EXT: No ___ edema bilaterally, sensation intact. 
SKIN: Dry. 
NEURO: CN II-XII grossly intact. 
ACCESS: Peripheral. 
 
Pertinent Results:
ADMISSION LABS
==============
___ 11:15AM BLOOD WBC-8.1# RBC-4.47* Hgb-14.0 Hct-40.5 
MCV-91 MCH-31.3 MCHC-34.6 RDW-11.3 RDWSD-37.3 Plt ___
___ 11:15AM BLOOD Neuts-83.2* Lymphs-6.3* Monos-9.5 
Eos-0.2* Baso-0.4 Im ___ AbsNeut-6.75*# AbsLymp-0.51* 
AbsMono-0.77 AbsEos-0.02* AbsBaso-0.03
___ 11:15AM BLOOD Plt ___
___ 11:15AM BLOOD Glucose-110* UreaN-25* Creat-0.8 Na-133 
K-5.5* Cl-90* HCO3-17* AnGap-32*
___ 11:15AM BLOOD ALT-14 AST-32 AlkPhos-82 TotBili-0.6
___ 11:15AM BLOOD Albumin-4.0 Calcium-9.7 Phos-3.0 Mg-2.0
___ 11:15AM BLOOD TSH-0.51
___ 11:16AM BLOOD Lactate-2.0 K-4.2

IMAGING
=======
CT NECK ___:
===========
IMPRESSION: 
1. Overall decrease in size of previously seen mass, now 
demonstrating an area of necrosis, and extending to the medial 
mandible, with no evidence of bony erosion. 
2. A saccular early enhancing an atrophic submandibular glands, 
consistent with post therapy changes. 
3. Decrease in size of previously enlarged lymph nodes, with no 
evidence of new abnormally enlarged lymph nodes. 

CXR ___
=======
IMPRESSION:  
Left basilar opacities likely reflect atelectasis. 

MRI ___
IMPRESSION:
 
 
1. Motion limited exam.
2. Peripherally enhancing and centrally nonenhancing right 
oropharyngeal
lesion may represent posttreatment changes.  However, residual 
tumor is not
excluded, given incomplete resolution of FDG avidity on the ___
PET-CT.  This would be best re-evaluated with a follow-up 
PET-CT.
3. Resolution of cervical lymphadenopathy.

DISCHARGE LABS
==============

___ 07:30AM BLOOD WBC-3.9* RBC-3.81* Hgb-11.7* Hct-35.4* 
MCV-93 MCH-30.7 MCHC-33.1 RDW-11.3 RDWSD-38.5 Plt ___
___ 07:30AM BLOOD Plt ___
___ 07:30AM BLOOD Glucose-95 UreaN-7 Creat-0.6 Na-140 K-5.0 
Cl-100 HCO3-32 AnGap-13
___ 07:30AM BLOOD Calcium-9.2 Phos-3.8 Mg-2.5

 
Brief Hospital Course:
Mr. ___ is a ___ year old male, with past history of 
Stage IV HPV oropharyngeal cancer, now presenting with 
increasing right jaw pain and poor po intake and weight loss.

# Trismus:
# Right Neck Swelling/Lymphadenopathy:
# Right Jaw Pain: CT scan of neck shows evidence of mass, could 
include recurrence of disease or scar tissue or post-treatment 
changes. CT shows overall decrease in size of previously seen 
mass but with an area of necrosis. Previous PET scan done that 
did show some residual activity. No visible ulceration on 
fiberoptic exam performed by ENT but did see cavitary lesion 
with fibrinous debris. No evidence of significant infection seen 
grossly but patient did spike a fever and he was started on 
unasyn and switched to Augmentin for total treatment course of 5 
days. Given concern for recurrence of disease, MRI was obtained 
which showed "Peripherally enhancing and centrally non-enhancing 
right oropharyngeal lesion may represent posttreatment changes. 
However, residual tumor is not excluded". Biopsy was not 
obtained. He was given his MRI images to bring to evaluation at 
Mass ___ and ___ on ___ after discharge. His pain was 
controlled with fentaynl patch 25 mg, po oxycodone ___ mg 
q4hours, gabapentin 300 TID. His pain is worsened by trismus and 
he will see speech and swallow as an outpatient to obtain 
swallowing therapy. 

# HPV+ Stage IV Oropharyngeal Carcinoma, s/p chemotherapy, XRT: 
Recent PET scan suggesting potential recurrence given uptake. 
See above for management.

# Thrush: Difficult to visualize because of trismus. However 
with history of thrush as well vomitus that he described as 
"cottage cheese", he was treated with fluconazole for total 
course of 7 days (end on ___.

# Severe Malnutrition
# Weight Loss: ___ to difficulty with eating because of pain, as 
well as likely underlying malignancy. Patient has lost 50 pounds 
since diagnosis with loss of 20 pounds in last three weeks. A 
PEG tube was placed on ___ and he was started on tube feeds. 
TUBE FEED PLANS: bolus 480 mL (2 cans) Osmolite 1.5
TID daily (2160 calories, 90 grams protein, 1097 mL free water). 
He should continue on a regular diet as tolerated.

# Graves Disease: Methimazole able to be crushed and continued 
on methimiazole 10 mg qhs.

# Anxiety/Insomnia: Continued on clonazepam

# Depression: Continued on citalopram

TRANSITIONAL ISSUES
===================
[] TUBE FEED PLAN: patient to continue to increase as an 
outpatient to 2 cans TID with feeding (tolerating 1 can at 
discharge). 
[] Pain management: please continue to address as outpatient. He 
was given prescriptions for oxycodone 10 mg PRN, Gabapentin 600 
mg TID, and fentanyl patch at 25 mcg. 
[] FOLLOW UP WITH ENT: Patient to f/u with primary oncologist, 
and second opinion Dr. ___. Information was faxed to Dr. ___ 
___ prior to discharge, and CDs regarding imaging were sent 
with patient. 

# HCP/Contact: ___ (Wife) ___
# Code: Full, Confirmed. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Methimazole 10 mg PO QHS 
2. ClonazePAM 0.5 mg PO QHS:PRN insomnia 
3. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate 

4. Citalopram 20 mg PO DAILY 

 
Discharge Medications:
1.  Bisacodyl 10 mg PO DAILY constipation 
RX *bisacodyl 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily 
Disp #*30 Capsule Refills:*0 
3.  Fentanyl Patch 25 mcg/h TD Q72H 
RX *fentanyl 25 mcg/hour Please place every 72 hours Q72 hours 
Disp #*5 Patch Refills:*0 
4.  Gabapentin 600 mg PO TID 
RX *gabapentin 300 mg 2 capsule(s) by mouth three times daily 
Disp #*90 Capsule Refills:*0 
5.  Senna 8.6 mg PO BID constipation 
RX *sennosides [senna] 8.6 mg 1 tab by mouth daily Disp #*30 
Tablet Refills:*0 
6.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - 
Severe 
RX *oxycodone 10 mg ___ tablet(s) by mouth every ___ hours Disp 
#*60 Tablet Refills:*0 
7.  Citalopram 20 mg PO DAILY  
8.  ClonazePAM 0.5 mg PO QHS:PRN insomnia  
9.  Methimazole 10 mg PO QHS  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=================
HPV+ Stage IV Oropharyngeal Carcinoma
Severe Malnutrition
Trismus
Thrush

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure meeting you at ___.

You were admitted to ___ because you were having right mouth 
pain and weight loss. While you were here, the ___, nose, and 
throat doctors saw ___ and used a scope to look and they found a 
mass in your neck. We tried to control your pain by changing 
your pain medications. Because you were losing a lot of weight 
and having pain with eating, we placed a gastric tube so that 
you could get tube feeds.

When you leave the hospital, you should see your cancer doctor 
and see Dr. ___ at ___ on ___. Please see below for your medication changes.

We wish you the best,
Your care team at ___

 
Followup Instructions:
___
